 | Akero Therapeutics, Inc. | |||
| NMS : AKRO || Location: United States | ||||
$20.26-0.74 (-3.52%) |
0.63 M | 20.12 - 21.51 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 7.844 M |
| March 15, 2024 | 9.471 M |
| Feb. 29, 2024 | 9.400 M |
| Feb. 15, 2024 | 8.895 M |
| Jan. 31, 2024 | 7.765 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.88 | -0.99 | -12.69% |
| 09/30/2023 | -0.69 | -0.71 | -2.17% |
| 06/30/2023 | -0.64 | -0.60 | 6.34% |
| 03/31/2023 | -0.69 | -0.55 | 19.75% |
| 12/31/2022 | -0.81 | -0.49 | 39.80% |
AKRO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 68.948M | Shares Float | 46.043M |
| Short Float | 7.844M | Market Cap | 1447.91M |
| Institution ownership | 92.13% | Insider ownership | 5.772% |
| Earnings Date | 05/14/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.89 | Forward EPS | -4.33 |